Cell Therapy for Cartilage Repair Fargo ND

Looking for information on Cell Therapy for Cartilage Repair in Fargo? We have compiled a list of businesses and services around Fargo that should help you with your search. We hope this page helps you find information on Cell Therapy for Cartilage Repair in Fargo.

David Lee Wiest, MD
(701) 237-9712
2301 25th St S
Fargo, ND
Specialties
Orthopedics
Gender
Male
Education
Medical School: Univ Of Mi Med Sch, Ann Arbor Mi 48109
Graduation Year: 1981

Data Provided By:
J Donald OpGrande
(701) 232-2848
2301 25th St S
Fargo, ND
Specialty
Hand Surgery

Data Provided By:
Gregory G Orson
(701) 234-8770
2400 32nd Ave S
Fargo, ND
Specialty
Hand Surgery

Data Provided By:
Dr.Philip Johnson
(701) 237-9712
2301 25Th St
Fargo, ND
Gender
M
Education
Medical School: Univ Of Nd Sch Of Med
Year of Graduation: 1984
Speciality
Orthopedic Surgeon
General Information
Hospital: Dakota Heartland Hlth System, Fargo, Nd
Accepting New Patients: Yes
RateMD Rating
3.0, out of 5 based on 2, reviews.

Data Provided By:
Andrew James Hvidston, MD
(701) 237-9712
2301 25th St S Ste A
Fargo, ND
Specialties
Orthopedics
Gender
Male
Education
Medical School: Univ Of Mn Med Sch-Minneapolis, Minneapolis Mn 55455
Graduation Year: 1984

Data Provided By:
David A Bailey
(701) 234-8770
2400 32nd Ave S
Fargo, ND
Specialty
Hand Surgery

Data Provided By:
Mark Allen Lundeen
(701) 237-9712
2301 25th St S
Fargo, ND
Specialty
Orthopedic Surgery

Data Provided By:
Jeffrey Paul Stavenger, MD
(701) 237-9712
2301 25th St S Ste A
Fargo, ND
Specialties
Orthopedics
Gender
Male
Education
Medical School: Univ Of Sd Sch Of Med, Vermillion Sd, 57069
Graduation Year: 1979

Data Provided By:
Andrew James Hvidston
(701) 237-9712
2301 25th St S
Fargo, ND
Specialty
Orthopedic Surgery

Data Provided By:
Bruce E Piatt
(701) 364-8000
3000 32nd Ave S
Fargo, ND
Specialty
Orthopedic Surgery

Data Provided By:
Data Provided By:

Cell Therapy for Cartilage Repair: A Review and Update

Research into repair techniques for damage to knee cartilage is moving right along. Surgeons in Europe and Australia are ahead of American surgeons as they have moved from first-generation cartilage repair through second generation methods to the more current third-generation approaches.

Only one type of third-generation cell therapy for cartilage repair is available in the United States: the matrix-induced autologous chondrocyte implantation or MACI. MACI is the subject of this review article. Although it is being used by U.S. surgeons, the U.S. Food and Drug Administration (FDA) has not yet approved this type of cell carrier yet.

But let's step back a minute and get some background information that will help you understand what's going on. The basic problem is one of damage to the articular (joint surface) cartilage of the knee. The hole or defect can be small but deep (all the way down to the bone). Sometimes, the defect is large (wide and deep).

The affected person experiences knee pain and joint swelling, locking, stiffness, and clicking. The symptoms can be bad enough to interfere with daily activities at home and work and create quite a bit of disability. Sports participation can be out of the question.

Because so many athletes are affected and given the fact that knee joint (articular) cartilage doesn't repair itself, researchers started looking for ways to treat cartilage injuries of this type. They tried scraping the area and smoothing it down, a procedure called debridement. They tried drilling tiny holes into the bone marrow to stimulate bone healing. That's called microfracture. And they tried taking healthy cartilage from one part of the knee and transferring it to the lesion to fill in the hole.

All of these treatment methods had problems. There wasn't one approach that could work well for all different types and sizes of cartilage defects. That's when cell therapy was developed. Healthy cartilage cells (chondrocytes) were harvested from the knee but instead of using them directly in the damaged area, they were transferred to a lab. In the lab, the cells were used to grow more cells. When there were enough cells to fill in the hole, they were reimplanted into the patient and covered with a patch made of periosteal (bone) cells.

That procedure was called autologous chondrocyte implantation (ACI). It was the first cell therapy devised for the problem of full-thickness (down to the bone) cartilage injuries. That's why it's considered a first-generation approach to cell therapy cartilage repair. But again there were problems. The procedure is invasive and requires a two-step (staged) surgical procedure. That means at least two surgeries with all of the possible costs and risks that go with staged procedures.

The next batch of autologous chondrocyte implants were improved and formed the second-generation techniques. Instead of covering the patched up hole with periosteum (bone cells), they t...

Click here to read the rest of this article from eOrthopod.com